| Name | Title | Contact Details |
|---|
We are at the cutting-edge of medical development – and through our advanced clinical trials, novel medical device development and in-house cellular manufacturing and quality control expertise, we intend to lead the industry. We are uniquely positioned and expect to maintain our leadership position though active collaborations with physicians, researchers, hospitals and blood banks on a wide range of clinical, cell-based approaches to medical treatment.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
1life Healthcare Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Metabolon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Durham, NC. To find more information about Metabolon, Inc., please visit www.metabolon.com
KishHealth System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. KishHealth System is based in Dekalb, IL. You can find more information on KishHealth System at www.kishhealth.org